Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers

British Journal of Haematology

Volumn 124, Issue 6, 2004, Pages 802-808

  Stevenson, John C ^a,d   Oladipo, Ayotunde ^a,b   Manassiev, Nick ^a,b   Whitehead, Malcolm I ^b   Guilford, Sandra ^c   Proudler, Anthony J ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c Janssen Cilag Ltd   (United Kingdom)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Haemostasis; Hormone replacement therapy; Insulin; Lipoproteins; Vascular function

Indexed keywords

APOLIPOPROTEIN A2; APOLIPOPROTEIN B; BLOOD CLOTTING FACTOR 7; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESTRADIOL; FIBRIN; GELATINASE A; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; NORETHISTERONE ACETATE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVITY; ESTROGEN THERAPY; FEMALE; FOREARM BLOOD FLOW; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MASTALGIA; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN CONTENT; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; VAGINA BLEEDING;

ADMINISTRATION, CUTANEOUS; ADULT; ANTHROPOMETRY; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DELAYED-ACTION PREPARATIONS; DRUG COMBINATIONS; EPIDEMIOLOGIC METHODS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEMOSTASIS; HUMANS; INSULIN; LIPIDS; LIPOPROTEINS; MIDDLE AGED; NORETHINDRONE; POSTMENOPAUSE;

EID: 1642375392     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.04846.x     Document Type: Article

References (30)

1. Blann, A.D. (1993) Is raised von Willebrand factor a marker of endothelial cell damage? Medical Hypotheses, 41, 419-424.
2. Blann, A.D. & Taberner, D.A (1995) A reliable marker of endothelial cell dysfunction: does it exist? British Journal of Haematology, 90, 244-248.
3. Blann, A.D., Amiral, J & McCollum, C.N. (1996) Circulating endothelial cell/leucocyte adhesion molecules in ischaemic heart disease. British Journal of Haematology, 95, 263-265.
4. Dollery, C.M., McEwan, J.R. & Henney, A.M. (1995) Matrix metalloproteinases and cardiovascular disease. Circulation Research, 77, 863-868.
5. Galis, Z.S., Sukhova, G.K., Lark, M.W. & Libby, P. (1994) Increased expression of matrix metalloproteinases and matrix degradating activity in vulnerable regions of human atherosclerotic plaques. Journal of Clinical Investigation, 94, 2493-2503.
6. Godsland, I.F., Gangar, K.F., Walton, C., Cust, M.P., Whitehead, M.I., Wynn, V. & Stevenson JC. (1993) Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism, 42, 846-853.
7. Goudev, A., Georgiev, D.B., Koycheva, N., Manasiev, N. & Kyurkchiev, S. (2002) Effects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women. Maturitas, 43, 49-53.
8. Grodstein, F., Manson, J.E., Colditz, G.A., Willett, W.C., Speizer, F.E. & Stampfer, M.J. (2000) A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Annals of Internal Medicine, 133, 933-941.
9. Hulley, S., Grady, D., Bush, T., Furberg, C., Herrington, D., Riggs, B. & Vittinghoff, E. (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Journal of the American Medical Association, 280, 605-613.
10. Hwang, S.J., Ballantyne, C.M., Sharrett, A.R., Smith, L.C., Davis, C.E., Gotto, A.M. & Boerwinkle, E. (1997) Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk in Communities (ARIC) study. Circulation, 96, 4219-4225.
11. Juhan-Vague, I., Alessi, M., Joly, P., Thirion, X., Vague, P., Declerk, P.J., Serradimigni, A. & Collen, D. (1989) Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response. Arteriosclerosis, 9, 362-367.
12. Koh, K.K., Cardillo, C., Bui, M.N., Hathaway, L., Csako, G., Waclawiw, M.A., Panza, J.A. & Cannon, R.O. (1999) Vascular effects of estrogen and cholesterol lowering therapies in hypercholesterolemic postmenopausal women. Circulation, 99, 354-360.
13. Leyva, F., Wingrove, C.S., Godsland, I.F. & Stevenson, J.C. (1998) The glycolytic pathway to coronary heart disease. Metabolism, 47, 657-662.
14. Leyva, F., Raucchaus, M., Anker, S.D., Proudler, A.J., Godsland, I.F., Stiefel, P., Coats, A.J.S., Poole-Wilson, P.A. & Stevenson, J.C. (2000) Non-invasive assessment of vascular function. Paradoxical vascular response to intravenous glucose in coronary heart disease. European Heart Journal, 21, 39-44
15. Lieberman, E.H., Gerhard, M.D., Uehata, A., Walsh, B.W., Selwyn, A.P., Ganz, P., Yeung, A.C. & Creager, M.A. (1994) Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease. Annals of Internal Medicine, 121, 936-941.
16. van der Mooren, M.J., de Graaf, J., Demacker, P.N., de Haan, AF. & Rolland, R. (1994) Changes in the low-density lipoprotein profile during 17 beta-oestradiol-dydrogesterone therapy in postmenopausal women. Metabolism, 43, 799-802.
17. Post, M.S., van der Mooren, M.J., Stehouwer, C.D., van Baal, W.M., Mijatovic, V., Schalkwijk, C.G. & Kenemans, P. (2002) Effects of transdermal and oral oestrogen replacement therapy on C-reactive protein levels in postmenopausal women: a randomised, placebo-controlled trial. Thrombosis and Haemostasis, 88, 605-610.
18. Pradhan, A.D., Manson, J.E., Rossouw, J.E., Siscovick, D.S., Mouton, C.P., Rifai, N., Wallace, R.B., Jackson, R.D., Pettinger, M.B. & Ridker, P. M (2002) Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. Journal of the American Medical Association, 288, 980-987.
19. Proudler, A.J., Ahmed, A.I.H., Crook, D., Fogelman, I., Rymer, J.M. & Stevenson, J.C. (1995) Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women. Lancet, 346, 89-90.
20. Proudler, A.J., Cooper, A., Whitehead, M.I. & Stevenson, J.C. (2003) Effect of oestrogen-only and oestrogen-progestogen replacement therapy upon circulating angiotensin I-converting enzyme activity in postmenopausal women. Clinical Endocrinology, 58, 30-35.
21. Scarabin, P.-Y., Oger, E. & Plu-Bureau, G. (2003) Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet, 362, 428-432.
22. Stevenson, J.C. (1996) Metabolic effects of the menopause and oestrogen replacement. In: Baillière's Clinical Obstetrics and Gynaecology. The Menopause: Key Issues (ed. by D. H. Barlow), pp. 449-467. Ballière Tindall, London.
23. Stevenson, J.C. (1998) Critical comment on: Randomized trial of estrogen and progestogen for secondary prevention of cardiovascular disease in postmenopausal women. Maturitas, 31, 77.
24. Stevenson, J.C. (2000) Cardiovascular effects of estrogens. Journal of Steroid Biochemistry and Molecular Biology, 74, 387-393.
25. Stork, S., von Schacky, C. & Angerer, P. (2002) The effect of 17beta-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial. Atherosclerosis, 165, 301-307.
26. Whitcroft, S.I., Crook, D., Marsh, M.S., Ellerington, M.C., Whitehead, M.I. & Stevenson, J.C. (1994) Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations. Obstetrics and Gynecology, 84, 222-226.
27. Wingrove, C.S., Garr, E., Godsland, I.F. & Stevenson, J.C. (1998) 17β-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells. Biochimica et Biophysica Acta, 1406, 169-174.
28. Winkler, U.H. (1992) Menopause, hormone replacement therapy and cardiovascular disease: a review of haemostaseological findings. Fibrinolysis, 6(Suppl. 3), 5-10.
29. Writing Group for the Women's Health Initiative Investigators. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Journal of the American Medical Association, 288, 321-333.
30. Zeitler, H., Ko, Y., Zimmermann, C., Nickenig, G., Glanzer, K., Walger, P., Sachinidis, A. & Vetter, H. (1997) Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction. European Journal of Medical Research, 2, 389-394.